secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2021-12-13T23:59:59+00:00
Accession:  0001104659-21-148822
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune appoints Richard Eisenstadt as CFO effective Dec 31, 2021
-------------------------------------------------------------------

- William Brown resigns as CFO effective Dec 31, 2021 to pursue other opportunities; no disagreement.
- Richard Eisenstadt appointed CFO effective Dec 31; annual salary $425,000, target bonus 40%, signing bonus $120,000.
- Eisenstadt receives 150,000 stock options and 50,000 RSUs; options vest 25% at one year, balance over 36 months.
- Eisenstadt previously CFO at Aytu BioPharma and Neos Therapeutics; raised over $340M in financings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000110465921148822/0001104659-21-148822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000110465921148822/tm2135141d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-148822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer